Six Major Pharma Companies To Invest Rs 5,260 Crore In Telangana

Hyderabad:  Major pharmaceutical companies have promised investments to the tune of Rs 5,260 crore for setting up new units and expanding operations in the existing ones in Telangana.

Representatives of the pharma industries called on Chief Minister A. Revanth Reddy at the Secretariat on Friday afternoon and signed memoranda of understanding with the State Government in his presence. They assured to set up green industry without giving scope for pollution. The MoUs would help create 12,490 new jobs in the pharma sector and the State Government would provide land for the units in the proposed pharma city.

According to the MoUs, MSN Laboratories would set up a manufacturing facility as well as research and development centres and Laurus Labs and Aurobindo Pharma would set up formulation units while the Gland Pharma would set up an R&D centre as well as injectables and drug substance manufacturing unit. Dr. Reddy’s Labs on its part would set up injectables and biosimilar facility while Hetero Labs assured to set up plant for finished dosages and injectables.

The Chief Minister directed the officials concerned to take steps to allot lands for the pharma units to set up their units besides ensuring the necessary facilities for their operations.

Dr. Reddy’s Labs director Satish Reddy, Laurus Labs executive director V.V. Ravi Kumar, Gland Pharma chief executive officer Srinivas and Hetero Group managing director Vamsi Krishna were among others who called on the Chief Minister.

Related Posts

NHS backs delayed‑release treatment for cystinosis

Decision expands options for eligible patients NHS England has recommended delayed‑release mercaptamine bitartrate for routine commissioning for eligible patients aged one year and above with nephropathic cystinosis. The decision provides…

Maharashtra FDA Permanently Cancels Licence of Pune Ayurvedic Drug Manufacturer Over Serious GMP and Quality Violations

Mumbai/Pune: In a major regulatory enforcement action aimed at safeguarding public health, the Maharashtra Food and Drug Administration (FDA) has permanently cancelled the Ayurvedic drug manufacturing licence of Pune-based M/s Inducare Pharma…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

NHS backs delayed‑release treatment for cystinosis

NHS backs delayed‑release treatment for cystinosis

Promotion of Drug Inspectors (Medical Devices) raises hopes of Effective Regulation & Patient Safety

Promotion of Drug Inspectors (Medical Devices) raises hopes of Effective Regulation & Patient Safety

Maharashtra FDA Permanently Cancels Licence of Pune Ayurvedic Drug Manufacturer Over Serious GMP and Quality Violations

Maharashtra FDA Permanently Cancels Licence of Pune Ayurvedic Drug Manufacturer Over Serious GMP and Quality Violations

Telangana DCA Seizes Gabapentin Tablets Falsely Sold as Nutraceuticals in Hyderabad

Telangana DCA Seizes Gabapentin Tablets Falsely Sold as Nutraceuticals in Hyderabad

Massive Blood Wastage in Gujarat: Over 85,000 Units Discarded Due to Storage Lapses and Expiry

Massive Blood Wastage in Gujarat: Over 85,000 Units Discarded Due to Storage Lapses and Expiry

AmeriHealth Home Healthcare Celebrates 5 Years of Compassionate Care

AmeriHealth Home Healthcare Celebrates 5 Years of Compassionate Care